CRP and nonpapillary renal cell carcinoma: CCRCC patients with lung metastatic lesions < 20 mm in diameter and lower CRP levels may achieve greater reductions in tumor size with sunitinib therapy than those with extra-pulmonary lesions, lung lesions ≥ 20 mm in diameter, and/or higher CRP levels.